Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.
United Therapeutics Corp (UTHR) has a market cap of $25.36B with year-over-year revenue growth of +23.6%. Net margin stands at 41.5%. The stock trades at a P/E ratio of 21.2.
Compared to other companies in the PHARMACEUTICAL PREPARATIONS sector, UTHR posted revenue growth of +23.6% and trades at a P/E of 21.2.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.